Integer Holdings Corp (ITGR) Stock Price & Analysis
Integer Holdings Corp (ITGR) rose 2.41% to USD 94.1 as of June 10, 2026 at 02:15 UTC, according to Nexqual real-time market data.
ITGR last closed at USD 91.89; the session ranged USD 92.81–94.57 on volume of 316,199 shares. Market capitalization is $3.20B, with a 52-week range of USD 62–123.78 (NYQ). Source: Nexqual, June 10, 2026 at 02:15 UTC.
Key Statistics (as of June 10, 2026 at 02:15 UTC)
| Price | USD 94.1 |
|---|---|
| Change | ▲ 2.41% (up) |
| Previous Close | USD 91.89 |
| Open | USD 92.7 |
| Day Range | USD 92.81 – 94.57 |
| 52-Week Range | USD 62 – 123.78 |
| Volume | 316,199 shares |
| Market Cap | $3.20B |
| Exchange | NYQ |
Technical Analysis (ITGR)
Nexqual's technical model rates ITGR "BUY" based on 5 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 02:15 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.08 (neutral) |
| vs SMA50 | Above (USD 87.95) |
| MACD | 1.42 (positive) |
Analyst Ratings (ITGR)
Wall Street analysts rate ITGR "Buy" based on 9 analysts, with a mean price target of USD 97.56 (range USD 84–115), per Nexqual as of June 10, 2026 at 02:15 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 97.56 |
| High Target | USD 115 |
| Low Target | USD 84 |
| Buy / Hold / Sell | 6 / 4 / 0 |
Earnings (ITGR)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 1.38 |
| Revenue Estimate | $450.50M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1.2 vs est 1.19 ▲ beat |
| 2025-12-31 | USD 1.76 vs est 1.7 ▲ beat |
| 2025-09-30 | USD 1.79 vs est 1.68 ▲ beat |
| 2025-06-30 | USD 1.55 vs est 1.55 ▼ miss |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
Financials & Fundamentals (ITGR)
| Total Revenue | $1.86B |
|---|---|
| Revenue Growth (YoY) | +0.50% |
| Gross Margin | +26.81% |
| Operating Margin | +8.16% |
| Profit Margin | +7.64% |
| ROE | +8.58% |
| Debt / Equity | 81.41 |
| Current Ratio | 3.76 |
| Total Cash | $8.12M |
| Total Debt | $1.38B |
| Free Cash Flow | $98.14M |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
Financial Health Score (ITGR)
Nexqual rates Integer Holdings Corp's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:15 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 27%, operating 8% |
| Balance Sheet | Mixed — $8M cash vs $1.38B debt |
| Cash Flow | Solid — FCF $98M, 5% margin |
| Efficiency | Mixed — ROE 9%, ROA 4.2% |
Ownership (ITGR)
| Insider Ownership | +1.40% |
|---|---|
| Institutional Ownership | +118.50% |
| Shares Outstanding | 33.95M |
| Float | 33.53M |
| Short % of Float | +16.05% |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
Leadership (ITGR)
Integer Holdings Corp is led by Payman Khales (age 55), CEO, President & Director, per Nexqual as of June 10, 2026 at 02:15 UTC.
| CEO, President & Director | Payman Khales (age 55) |
|---|---|
| Executive VP & CFO | Diron Smith (age 51) |
| President of Cardio & Vascular | Andrew Senn (age 43) |
| President of Cardiac Rhythm Management & Neuromodulation | Jim Stephens (age 51) |
| Director of Investor Relations | Kristen Marie Stewart C.F.A. |
Major Backers & Investors (ITGR)
Notable institutional backers of Integer Holdings Corp include Invesco, Morgan Stanley, Alliancebernstein L.P., according to Nexqual as of June 10, 2026 at 02:15 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 5.8% |
| Morgan Stanley | 4.53% |
| Alliancebernstein L.P. | 3.84% |
| Irenic Capital Management LP | 3.72% |
| AIM Sector Funds (Invesco Sector Funds)-INVESCO SMALL CAP VALUE FUND | 3.32% |
| Earnest Partners LLC | 3.07% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 24.31% |
| Vanguard Group | 18.73% |
| Dimensional Fund Advisors | 4.37% |
| State Street | 4.12% |
Source: Nexqual, June 10, 2026 at 02:15 UTC.
From Integer Holdings Corp's Latest SEC 10-K Filing (filed 2026-02-23)
Key Strengths & Strategy (as disclosed to the SEC)
- Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.
- The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
- In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines.
- Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LIVN | LivaNova PLC | USD 77.17 | ▲ 6.65% |
| CNMD | CONMED Corporation | USD 36.9 | ▲ 4.95% |
| GKOS | Glaukos Corporation | USD 126.34 | ▲ 1.07% |
| MMSI | Merit Medical Systems, Inc. | USD 67.51 | ▲ 4.7% |
| HAE | Haemonetics Corporation | USD 78.71 | ▲ 10.42% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:15 UTC. This page is informational and not investment advice.